Insulin |
Ag |
Male Sprague Dawley rats |
Increased levels of IRS-1, Akt, GSK3β |
[288] |
Ag |
Male albino rats |
Reduction of blood glucose, and increase in serum insulin, glucokinase activity, expression of insulin, insulin receptor, GLUT-2 and glucokinase genes |
[277] |
Au |
RIN-5F cells |
Increased insulin secretion, decreased apoptosis, and increased gene and protein expression of IRS-1, GLUT2, and the insulin receptor |
[284] |
Gadofullerene (functionalized with β-alanine) |
Diabetic mice |
Activated IRS2/PI3K/Akt signalling pathway, normalized blood sugar levels |
[154] |
Ni |
Rat testicular Sertoli-germ cells |
Upregulation of the gene and protein expression of IGFBP-3 |
[272] |
Platinum |
HepG2 cells |
Increased activation of Akt |
[26] |
Se |
Diabetic male Wistar rats |
Normalized fasting blood glucose level, reduction of insulin level, normalized levels of phosphorylated: IRS-1, Akt, GSK-3β, and AMPK |
[155] |
Superparamagnetic iron oxide |
Diabetic male Wistar rats |
Normalized fasting blood glucose levels, reduction of insulin level, increased levels of P13K and GSK-3β resulting in increased glucose uptake and decreased insulin resistance |
[275] |
TiO2
|
Male CD-1 mice |
Increase in blood glucose level, increased IRS-1 phosphorylation, and decreased phosphorylation of Akt |
[289] |
ZnO |
Male Sprague-Dawley rats |
Decreased serum level of IGF-1 |
[270] |
ZnO |
Streptozotocin-induced diabetic male albino rats |
Normalized fasting blood glucose, insulin, and insulin resistance score levels, and improved diabetic vascular complications |
[286,287] |
ZnO |
Male albino rats |
Reduction of blood glucose, and increase in serum insulin, glucokinase activity, expression of insulin, insulin receptor, GLUT-2 and glucokinase genes |
[39] |
ZnO |
Obese C57BL/6 mice |
Decreased insulin resistance |
[279] |
Calcium |
Ag |
SH-SY5Y |
Induced release of calcium from ER |
[295] |
Ag |
SH-SY5Y, Sprague-Dawley rats |
Increased intracellular calcium level, activation of CaMKKβ and AMPK |
[298] |
Ag |
Zebrafish embryos |
Downregulation of calcium signaling |
[301] |
Ag |
Rat CGCs |
Increased intracellular calcium level |
[296] |
Ag |
Human embryonic stem cell-derived glutamatergic neurons |
Decreased expression of NMDA receptor subunits |
[305] |
Ag |
Male Wistar rats |
Increased gene expression of NMDA receptor subunits NR1, NR2A, and NR2B in the brain tissue |
[306] |
Carbon |
PASMCs |
Increased intracellular calcium level |
[297] |
Carbon black |
Human pulmonary artery endothelial cells |
Increased intracellular calcium level |
[49] |
CuO |
RCC |
Increased intracellular calcium level |
[299] |
NiO |
BEAS-2B cells |
Increased intracellular calcium level |
[300] |
MgO |
Male Wistar rats |
Decreased level of glutamate, increased gene expression of NMDA subunit NR2B in the hippocampus |
[303] |
Si |
HUVECs |
Increased intracellular calcium level, decreased activity of Ca2+-ATPase, Ca2+/Mg2+-ATPase, and Na+/K+-ATPase |
[347] |
SiO2
|
PASMCs |
Increased intracellular calcium level |
[52] |
TiO2
|
PASMCs |
Increased intracellular calcium level |
[52] |
Nitric Oxide |
Ag |
Rat smooth muscle tracheal rings |
Increased iNOS protein expression, ●NO production, activation of muscarinic receptors |
[310] |
Ag |
ASM cells from male Wistar rats |
Increased iNOS expression, ●NO production, and activation of muscarinic receptors |
[311] |
Ag |
SVEC4-10 mouse endothelial cells and hFOB 1.19 cells |
Increased iNOS expression and ●NO production |
[313,348] |
Ag |
Human embryonic stem cell-derived glutamatergic neurons |
Increased iNOS and nNOS expression |
[305] |
Ag |
Chicken sertoli cells |
Increased gene expression of iNOS and eNOS |
[314] |
Ag |
LPS-induced RAW 264.7 cells |
Decreased ●NO and iNOS expression |
[168] |
Ag |
Isolated perfused hearts from rats |
Increased ROS, decreased ●NO production, decreased iNOS and eNOS expression, but increased expression of phosphorylated eNOS |
[315] |
Ag |
C57BL/6J male mice fed high-fat Western diet |
Decreased iNOS gene expression |
[317] |
Au |
RAW 264.7 cells |
Decreased ●NO and iNOS expression |
[150,168,218,318] |
Au |
Mouse BV-2 microglial cells |
Decreased ●NO and iNOS expression |
[160] |
Au |
Rhesus macaque choroid-retinal endothelial RF/6A cells |
Decreased VEGF-induced eNOS phosphorylation |
[312] |
Carbon |
Aluminum-induced Alzheimer’s male albino Wistar rats |
Normalized iNOS expression |
[334] |
Carbon (graphene QDs) |
HepG2 cells |
Decreased ●NO production |
[335] |
Carbon (multi-walled nanotubes) |
RAW 264.7 cells |
Increased iNOS expression |
[342] |
Chitosan |
Male albino Wistar rats induced with carcinoma |
Normalized ●NO level |
[344] |
Se (capped with Ganoderma lucidum polysaccharides) |
LPS-induced RAW 264.7 cells |
Normalized ●NO level |
[156] |
CeO2
|
Male Sprague Dawley rats with LPS-induced sepsis and Kupffer cell macrophages |
Decreased iNOS gene and protein expression and ●NO production |
[36,213] |
CeO2
|
Male Sprague Dawley rats |
Decreased ●NO production |
[35] |
Cu |
Wistar albino rats with induced myocardial infarction |
Normalized serum ●NO level |
[331] |
Cu |
Male Sprague-Dawley rats |
Increased levels of ROS, iNOS, and ●NO in the liver tissue |
[332] |
Cu |
LPS-induced primary macrophages from C57BL/6 mice |
Normalized ●NO level |
[333] |
Cu |
LPS-induced primary mouse macrophages |
Normalized ●NO level |
[74] |
Hydroxyapatite |
HUVECs |
Decreased ●NO production and phosphorylated eNOS expression |
[345] |
MnO2
|
Cytokine-challenged cartilage explants |
Decreased ●NO level |
[343] |
Propylene glycol alginate sodium sulfite |
Streptozotocin-induced diabetic male Wistar rats |
Inhibited diabetes-induced decrease in NOS activity and ●NO level |
[346] |
Pt |
LPS-induced RAW 264.7 cells |
Decreased ●NO and iNOS expression |
[327,349] |
Pt |
THP-1 cells |
Increased ●NO level |
[25] |
TiO2 nanotubes |
HUVECs |
Downregulation of eNOS transcription factors (KLF2 and KLF4), and decreased ●NO level, resulting in decreased eNOS expression |
[325] |
Si |
Male Wistar rats |
Increased ●NO level in the liver and kidneys |
[338] |
Si |
HUVECs |
Increased ●NO levels, increased iNOS expression, and decreased eNOS expression |
[339] |
Si |
HUVECs |
Decreased ●NO level, decreased expression of total NOS and eNOS, and increased iNOS expression |
[340] |
Superparamagnetic FeO |
LPS-induced RAW 264.7 cells |
Increased ●NO level |
[117] |
Superparamagnetic FeO |
RAW 264.7 cells |
Decreased iNOS expression |
[336,337] |
ZnO |
LPS-induced RAW 264.7 cells |
Normalized iNOS expression and ●NO production |
[326] |
ZnO |
Streptozotocin-induced diabetic male albino rats |
Normalized iNOS expression and ●NO production |
[287] |
ZnO |
Bacterial infection with nontypeable Haemophilus influenzae infected RAW 264.7 cells and C57BL/6 mice |
Normalized iNOS expression and ●NO production |
[350] |
ZnO |
Human coronary artery endothelial cells |
Increased iNOS and ●NO levels |
[328] |
ZnO |
BALB/c mice macrophages |
Increased iNOS and ●NO levels |
[101] |
ZnO |
THP-1 cells |
Increased iNOS and ●NO levels |
[137] |
ZnFe2O4
|
Human amnion epithelial cells |
Increased iNOS expression |
[330] |